Rachel Eguia - Concepedia

Author

Rachel Eguia

Fred Hutch Cancer Center ORCID

Also Known As

Rachel Eguia, Rachel T Eguia, Rachel T. Eguia

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center Howard Hughes Medical Institute University of Washington Icahn School of Medicine at Mount Sinai Africa Health Research Institute

About

Rachel Eguia is an author at Fred Hutch Cancer Center specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	2.2K
2	Immunology	13	13	2.1K
3	Cell Biology	3	3	276
4	Molecular Biology	2	2	83
5	Epidemiology	1	1	35

Rachel Eguia

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Cell Host & Microbe	2020	1.1K
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, Viruses Spike ProteinSars-cov-2 SpikeSynthetic VirologyViral PathogenesisImmunology	2020	866
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Katharine H. D. Crawford, Adam S. Dingens, Rachel Eguia, The Journal of Infectious Diseases VaccinationViral PersistenceViral Spike ProteinViral PathogenesisImmunology	2020	278
A human coronavirus evolves antigenically to escape antibody immunity Rachel Eguia, Katharine H. D. Crawford, Terry Stevens‐Ayers, PLoS Pathogens VaccinationViral EvolutionVaccine TargetViral PathogenesisImmunology	2021	247
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, Viral DiagnosticsSynthetic VirologyViral PathogenesisImmunologyViral Structural Protein	2020	223
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk,	2020	190
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin Juhye Lee, Rachel Eguia, Seth J. Zost, eLife	2019	136
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection Katharine H. D. Crawford, Adam S. Dingens, Rachel Eguia, Antibody TitersViral PersistenceSars-cov-2 InfectionViral Spike ProteinHumoral Response	2020	104
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein M. Alejandra Tortorici, Alexandra C. Walls, Anshu Joshi, Cell Virus StructureViral PathogenesisImmunologyVirologyReceptor Recognition	2022	87
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy Allison J. Greaney, Tyler N. Starr, Rachel Eguia, PLoS Pathogens Sars-cov-2 VariantImmunologyViral PathogenesisImmunodominancePathology	2022	77

Page 1